Icon

NUPLAZID (nda207318)- (EQ 17MG BASE,EQ 10MG BASE)

PIMAVANSERIN TARTRATE ACADIA PHARMS INC
EQ 17MG BASE,EQ 10MG BASE
Yes No
2030-Apr-29 2021-Apr-29
None None
None No
NUPLAZID is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis.
1 0 0
Total Other Developers 4
Drugs with Suitability No
EQ 17MG BASE ** ** - - -
EQ 10MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.